Biotechnology Stocks
| # | Letzte 7 Tage | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1860 | CLDX Celldex Therapeutics, Inc. - Common Stock | 29.28 USD | -3.78% | -9.01% | -24.83% | +7.49% | 2.30 B USD | ||
| 1870 | SLS SELLAS Life Sciences Group, Inc. - Common Stock | 11.27 USD | -0.35% | -0.53% | -17.80% | +477.95% | 2.28 B USD | ||
| 1890 | IMNM Immunome, Inc. - Common Stock | 19.32 USD | +1.15% | -7.52% | -27.18% | +38.00% | 2.19 B USD | ||
| 1902 | AUPH Aurinia Pharmaceuticals Inc - Common Shares | 16.20 USD | +1.19% | +1.57% | +1.44% | +35.79% | 2.16 B USD | ||
| 1906 | BCRX BioCryst Pharmaceuticals, Inc. - Common Stock | 8.29 USD | -1.31% | +2.09% | -8.50% | +14.50% | 2.12 B USD | ||
| 1912 | VERA Vera Therapeutics, Inc. - Class A Common Stock | 29.76 USD | -1.62% | -3.97% | -14.58% | +0.07% | 2.14 B USD | ||
| 1924 | RXRX Recursion Pharmaceuticals, Inc. - Class A Common Stock | 3.95 USD | -7.49% | -2.95% | +15.84% | -35.56% | 2.11 B USD | ||
| 1926 | VCEL Vericel Corporation - Common Stock | 40.04 USD | -1.72% | +1.52% | +3.41% | +10.15% | 2.05 B USD | ||
| 1931 | VRDN Viridian Therapeutics, Inc. - Common Stock | 18.33 USD | +0.27% | -3.48% | -20.68% | -18.35% | 2.08 B USD | ||
| 1937 | PHVS Pharvaris N.V. - Ordinary Shares | 31.12 USD | -1.77% | +0.35% | -17.89% | +31.75% | 2.03 B USD | ||
| 1955 | MLYS Mineralys Therapeutics, Inc. - Common Stock | 22.37 USD | +1.27% | -5.69% | -27.53% | -44.59% | 1.98 B USD | ||
| 1976 | FTRE Fortrea Holdings Inc. - Common Stock | 20.36 USD | -0.97% | +4.95% | +20.76% | +99.61% | 1.94 B USD | ||
| 1978 | SRPT Sarepta Therapeutics, Inc. - Common Stock | 18.22 USD | +4.11% | +3.70% | -11.68% | -22.24% | 1.92 B USD | ||
| 1982 | AGIO Agios Pharmaceuticals, Inc. - Common Stock | 31.92 USD | +0.41% | -1.72% | -3.68% | -26.43% | 1.91 B USD | ||
| 1984 | XERS Xeris Biopharma Holdings, Inc. - Common Stock | 10.19 USD | +0.79% | +10.16% | +19.32% | +24.42% | 1.86 B USD | ||
| 1988 | VIR Vir Biotechnology, Inc. - Common Stock | 11.13 USD | -3.39% | -1.42% | +0.82% | +86.12% | 1.88 B USD | ||
| 1989 | TRVI Trevi Therapeutics, Inc. - Common Stock | 12.82 USD | -2.44% | -9.59% | -23.83% | +30.42% | 1.83 B USD | ||
| 1997 | MRVI Maravai LifeSciences Holdings, Inc. - Class A common stock | 7.20 USD | -3.10% | -4.00% | +1.69% | +114.29% | 1.87 B USD | ||
| 2007 | URGN UroGen Pharma Ltd. - Ordinary Shares | 36.96 USD | -9.19% | -8.85% | -15.65% | +94.53% | 1.81 B USD | ||
| 2014 | GPCR Structure Therapeutics Inc - American Depositary Shares | 25.62 USD | -3.97% | -11.59% | -37.86% | -4.19% | 1.83 B USD |
Nachrichten Biotechnology Stocks
Kymera Therapeutics: Raymond James startet Coverage mit „Outperform“-Rating
Raymond James startet Coverage für Nektar-Aktie mit "Market Perform"
Raymond James nimmt Coverage für Palisade Bio mit "Outperform" auf
Raymond James bestätigt Liquidia-Rating trotz rechtlicher Unsicherheiten
Ginkgo Bioworks gewährt NSF X-Labs Zugang zu autonomem Labor
AbCellera präsentiert Phase-1/2-Daten zu Medikamentenkandidaten gegen Menopause-Beschwerden
Quantum-Si: Nachweis von 19 Aminosäuren markiert wichtigen Meilenstein für Proteus-Plattform
Gainers Biotechnology Stocks
GRDX GridAI Technologies Corp. - Common Stock | 4.79 | +16.26% |
CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
SRZN Surrozen, Inc. - Common Stock | 28.00 | +11.38% |
ANL Adlai Nortye Ltd - American Depositary Shares | 15.54 | +10.60% |
QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
ENLV Enlivex Ltd. - Ordinary Shares | 0.27 | -12.90% |
MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |